查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1645728

全球无血清和特种培养基市场（按产品、应用和最终用户划分）- 机会分析和产业预测，2024 年至 2033 年

Serum Free and Specialty Media Market By Product, By Application, By End User : Global Opportunity Analysis and Industry Forecast, 2024-2033
出版日期: | 出版商: Allied Market Research | 英文 300 Pages | 商品交期: 2-3个工作天内

价格
简介目录

无血清和特种培养基市场规模预计在 2023 年达到 23 亿美元，预计到 2033 年将达到 69 亿美元，2024 年至 2033 年的复合年增长率为 11.6%。

无血清及特殊培养基市场-IMG1

无血清培养基和专用培养基是实验室和製药业使用的细胞培养配方，可支持多种细胞类型的生长。这种培养基不含有动物血清（例如牛）来提供生长因子，而是用化学合成的替代品替代。无血清培养基和特殊培养基用于疫苗开发、蛋白质和病毒生产以及基因治疗。

为满足对单株抗体和疫苗日益增长的需求，生物製药行业的发展导致对无血清和专用培养基的需求激增，从而增加了市场的发展。此外，食品药物管理局等多个监管机构已强调在生物製药中停止使用动物源产品，这推动了无血清和特殊培养基市场的发展。目前推动市场的一个显着趋势是 3D 细胞培养模型培养基的开发。 3D 细胞培养模型需要模拟体内环境的细胞生长控制条件。无血清培养基和特殊培养基是专门为满足每种细胞培养的特定需求而配製的，因此可以满足您的 3D 模型的受控环境要求。

然而，实现无血清和专用培养基的精确配方以实现最佳细胞生长是一个耗时而复杂的过程，带来扩充性挑战并阻碍市场成长。相反，由于细胞疗法的安全性和在治疗疾病方面的巨大潜力，医疗保健领域越来越多地采用细胞疗法，这预计将为无血清和特种培养基市场带来丰厚的机会。根据全球最大的生物医学图书馆美国国家医学图书馆的审查，到2023年第一季，全球将有超过100种基因、细胞和RNA疗法核准，约有3700种疗法处于临床或临床前开发阶段。该培养基有望为细胞治疗方法开闢新的途径，因为它为治疗细胞的生长提供了优化的、无污染的环境。

部分回顾

无血清和特殊培养基市场根据产品类型、应用、最终用户和地区进行细分。依产品类型分为CHO培养基、HEK培养基、融合瘤培养基等。根据应用，市场分为生物製药製造、组织工程/再生医学和其他。根据最终用户，市场分为製药和生物製药公司、研究和学术机构等。按地区分析，涵盖北美（美国、加拿大、墨西哥）、欧洲（德国、法国、英国、义大利、西班牙和其他欧洲国家地区）、亚太地区（日本、中国、印度、澳洲、韩国和其他亚太地区）、拉丁美洲和中东及非洲（巴西、中国、非洲、阿拉伯和其他南美地区）。

主要发现

根据产品类型，CHO 媒体部分在 2023 年占据了市场主导地位。

根据应用，生物製药生产领域在 2023 年占据了市场的最高份额。

根据最终用户，製药和生物技术公司部门在 2023 年占据了相当大的市场。

按地区划分，预计北美将在 2023 年创造最高收益。

全球无血清和特种培养基市场的主要主要企业有赛默飞世尔、默克、丹纳赫集团 (Cytiva)、赛多利斯、Biotechne、Pan-Biotec、康宁、富士胶片欧文科学、龙沙和 MP Biomedicals。这些主要企业正在采取各种关键发展策略，包括产品发布、业务扩张、地理扩张和投资，以在竞争激烈的市场中站稳脚跟。

相关人员的主要利益

本报告定量分析了 2023 年至 2033 年无血清和特种培养基市场细分、当前趋势、估计趋势和动态，并确定了一般无血清和特种培养基市场中的机会。

它为市场研究提供与市场驱动因素、市场限制因素和市场机会相关的资讯。

波特五力分析揭示了买家和供应商的潜力，帮助相关人员做出利润驱动的商业决策，并加强供应商-买家网络。

对无血清和特种培养基市场进行详细細項分析有助于发现市场机会。

每个地区的主要国家都根据收益贡献进行划分。

市场公司的定位有利于基准化分析，并能清楚了解市场公司的当前地位。

报告包括区域和全球无血清和特种培养基市场趋势、主要企业、细分市场、应用领域和市场成长策略的分析。

此报告可进行客製化（需支付额外费用和时间表）

  • 国家、地区和全球层面的患者/流行病学资料
  • 监管指南
  • 根据客户兴趣提供额外的公司简介
  • 按国家或地区进行的额外分析 - 市场规模和预测
  • 扩展公司简介列表
  • 历史市场资料
  • SWOT 分析

目录

第 1 章 简介

第 2 章执行摘要

第三章 市场概况

  • 市场定义和范围
  • 主要发现
    • 关键影响因素
    • 重大投资机会
  • 波特五力分析
  • 市场动态
    • 驱动程式
      • 提高生物製药产量
      • 专门细胞培养技术的进展
      • 个人化医疗和细胞治疗方法的发展
    • 限制因素
      • 克服严格的监管要求和高成本
    • 机会
      • 转向无动物、永续和道德的研究方法

第 4 章 无血清培养基及特殊培养基市场（依产品划分）

  • 概述
  • CHO 培养基
  • HEK 培养基
  • 杂交融合瘤培养基
  • 其他的

第五章 无血清培养基及特殊培养基市场（依应用）

  • 概述
  • 生物製药製造
  • 组织工程与再生医学
  • 其他的

第 6 章 无血清培养基及专用培养基市场（依最终用户）

  • 概述
  • 製药和生物技术公司
  • 研究和学术机构
  • 其他的

第 7 章 无血清和特种培养基市场（按地区）

  • 概述
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 其他的
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 其他的
  • 拉丁美洲、中东和非洲
    • 巴西
    • 沙乌地阿拉伯
    • 南非
    • 其他的

第八章 竞争格局

  • 介绍
  • 关键成功策略
  • 前 10 家公司的产品映射
  • 竞争仪錶板
  • 竞争热图
  • 2023年主要企业的定位

第九章 公司简介

  • Sartorius AG
  • Danaher Corporation
  • Fujifilm Holdings Corporation
  • Merck KGaA
  • Lonza
  • PAN-Biotech
  • Corning Incorporated
  • MP Biomedicals
  • Bio-Techne
  • Thermo Fisher Scientific Inc.
简介目录
Product Code: A197307

The serum free and specialty media market was valued at $2.3 billion in 2023 and is estimated to reach $6.9 billion by 2033, exhibiting a CAGR of 11.6% from 2024 to 2033.

Serum Free and Specialty Media Market - IMG1

A serum-free and specialty media is a cell culture formulation used in laboratories and pharmaceutical industries to support the growth of different types of cells. This type of media does not contain animal serum such as fetal bovine serum for the supply of growth factors; instead, it is replaced by chemically synthesized alternatives. Serum-free and specialty media is utilized in vaccine development, protein & virus production, and gene therapy.

Expansion of the biopharmaceutical industry to cater to increasing demand for monoclonal antibodies and vaccines has upsurged the requirement for serum-free and specialty media, hence augmenting the development of the market. In addition, several regulatory bodies such as the Food and Drug Administration are stressing the elimination of animal-based product usage in biopharmaceuticals, which is driving the serum-free and specialty media market. A notable trend acquiring traction in the market currently is the development of media for 3D cell culture models, which require controlled conditions that mimic the in-vivo environment for cell growth. The serum-free and specialty media aligns with the controlled environment requirement of the 3D model as its formulation is particularly created to serve the specialized purpose of each cell culture.

However, achieving the accurate formulation of serum-free and specialty media for optimal cell growth is a time-consuming, complex process that presents scalability challenges and hampers the market growth. On the contrary, rise in the adoption of cell therapies in the medicine sector due to their safety and promising potential for curing diseases is expected to present lucrative opportunities for the serum-free and specialty media market. As per a review article on the National Library of Medicine-the largest biomedical library globally-by the end of the first quarter of 2023, there were more than 100 different approved gene, cell, and RNA therapies across the globe and approximately 3,700 therapies were in the clinical or preclinical development stage. As the media provides an optimized and contamination-free environment for the growth of therapeutic cells, it is projected to witness novel avenues with increasing cell therapy procedures.

Segment Review

The serum-free and specialty media market is segmented into product type, application, end user, and region. By product type, the market is segregated into CHO media, HEK media, hybridoma media, and others. As per application, it is classified into biopharmaceutical production, tissue engineering & regenerative medicine, and others. According to end user, it is classified into pharmaceutical & biopharmaceutical companies, research & academic institutes, and others. Region wise, it is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

Key Findings

By product type, the CHO media segment dominated the market in 2023.

As per application, the biopharmaceutical production segment held the highest share of the market in 2023.

According to end user, the pharmaceutical & biotechnology companies segment acquired a notable stake in the market in 2023.

Region wise, North America was the highest revenue generator in 2023.

Competition Analysis

Major key players that operate in the global serum-free and specialty media market are Thermo Fischer, Merck KGAA, Danaher Corporation (Cytiva), Sartorius AG, Biotechne, Pan-Biotec, Corning, FUJIFILM Irvine Scientific., Lonza, and MP Biomedicals. These major players have adopted various key development strategies such as product launch, expansion, geographical expansion, and investment to strengthen their foothold in the competitive market.

Key Benefits for Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the serum free and specialty media market analysis from 2023 to 2033 to identify the prevailing serum free and specialty media market opportunities.

The market research is offered along with information related to key drivers, restraints, and opportunities.

Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.

In-depth analysis of the serum free and specialty media market segmentation assists to determine the prevailing market opportunities.

Major countries in each region are mapped according to their revenue contribution to the global market.

Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.

The report includes the analysis of the regional as well as global serum free and specialty media market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Patient/epidemiology data at country, region, global level
  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • SWOT Analysis

Key Market Segments

By Product

  • CHO Media
  • HEK Media
  • Hybridoma Media
  • Others

By Application

  • Biopharmaceutical Production
  • Tissue Engineering and Regenerative Medicine
  • Others

By End User

  • Pharmaceutical and Biotechnology Companies
  • Research and Academic Institutes
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of Asia-Pacific

Key Market Players:

    • Corning Incorporated
    • MP Biomedicals
    • Fujifilm Holdings Corporation
    • Lonza
    • Merck KGaA
    • Thermo Fisher Scientific Inc.
    • Danaher Corporation
    • PAN-Biotech
    • Bio-Techne
    • Sartorius AG

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
    • 3.3.1. High bargaining power of suppliers
    • 3.3.2. Moderate threat of new entrants
    • 3.3.3. Moderate threat of substitutes
    • 3.3.4. Moderate intensity of rivalry
    • 3.3.5. High bargaining power of buyers
  • 3.4. Market dynamics
    • 3.4.1. Drivers
      • 3.4.1.1. Rise in Biopharmaceutical Production
      • 3.4.1.2. Advancements in Specialty Cell Culture Technology
      • 3.4.1.3. Growth In Personalized Medicine and Cell-Based Therapies
    • 3.4.2. Restraints
      • 3.4.2.1. Navigating Strict Regulatory Requirements and High Costs
    • 3.4.3. Opportunities
      • 3.4.3.1. The shift towards animal-free, sustainable, and ethical research practices

CHAPTER 4: SERUM FREE AND SPECIALTY MEDIA MARKET, BY PRODUCT

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. CHO Media
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
  • 4.3. HEK Media
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country
  • 4.4. Hybridoma Media
    • 4.4.1. Key market trends, growth factors and opportunities
    • 4.4.2. Market size and forecast, by region
    • 4.4.3. Market share analysis by country
  • 4.5. Others
    • 4.5.1. Key market trends, growth factors and opportunities
    • 4.5.2. Market size and forecast, by region
    • 4.5.3. Market share analysis by country

CHAPTER 5: SERUM FREE AND SPECIALTY MEDIA MARKET, BY APPLICATION

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Biopharmaceutical Production
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. Tissue Engineering and Regenerative Medicine
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country
  • 5.4. Others
    • 5.4.1. Key market trends, growth factors and opportunities
    • 5.4.2. Market size and forecast, by region
    • 5.4.3. Market share analysis by country

CHAPTER 6: SERUM FREE AND SPECIALTY MEDIA MARKET, BY END USER

  • 6.1. Overview
    • 6.1.1. Market size and forecast
  • 6.2. Pharmaceutical and Biotechnology Companies
    • 6.2.1. Key market trends, growth factors and opportunities
    • 6.2.2. Market size and forecast, by region
    • 6.2.3. Market share analysis by country
  • 6.3. Research and Academic Institutes
    • 6.3.1. Key market trends, growth factors and opportunities
    • 6.3.2. Market size and forecast, by region
    • 6.3.3. Market share analysis by country
  • 6.4. Others
    • 6.4.1. Key market trends, growth factors and opportunities
    • 6.4.2. Market size and forecast, by region
    • 6.4.3. Market share analysis by country

CHAPTER 7: SERUM FREE AND SPECIALTY MEDIA MARKET, BY REGION

  • 7.1. Overview
    • 7.1.1. Market size and forecast By Region
  • 7.2. North America
    • 7.2.1. Key market trends, growth factors and opportunities
    • 7.2.2. Market size and forecast, by Product
    • 7.2.3. Market size and forecast, by Application
    • 7.2.4. Market size and forecast, by End User
    • 7.2.5. Market size and forecast, by country
      • 7.2.5.1. U.S.
      • 7.2.5.1.1. Market size and forecast, by Product
      • 7.2.5.1.2. Market size and forecast, by Application
      • 7.2.5.1.3. Market size and forecast, by End User
      • 7.2.5.2. Canada
      • 7.2.5.2.1. Market size and forecast, by Product
      • 7.2.5.2.2. Market size and forecast, by Application
      • 7.2.5.2.3. Market size and forecast, by End User
      • 7.2.5.3. Mexico
      • 7.2.5.3.1. Market size and forecast, by Product
      • 7.2.5.3.2. Market size and forecast, by Application
      • 7.2.5.3.3. Market size and forecast, by End User
  • 7.3. Europe
    • 7.3.1. Key market trends, growth factors and opportunities
    • 7.3.2. Market size and forecast, by Product
    • 7.3.3. Market size and forecast, by Application
    • 7.3.4. Market size and forecast, by End User
    • 7.3.5. Market size and forecast, by country
      • 7.3.5.1. Germany
      • 7.3.5.1.1. Market size and forecast, by Product
      • 7.3.5.1.2. Market size and forecast, by Application
      • 7.3.5.1.3. Market size and forecast, by End User
      • 7.3.5.2. France
      • 7.3.5.2.1. Market size and forecast, by Product
      • 7.3.5.2.2. Market size and forecast, by Application
      • 7.3.5.2.3. Market size and forecast, by End User
      • 7.3.5.3. UK
      • 7.3.5.3.1. Market size and forecast, by Product
      • 7.3.5.3.2. Market size and forecast, by Application
      • 7.3.5.3.3. Market size and forecast, by End User
      • 7.3.5.4. Italy
      • 7.3.5.4.1. Market size and forecast, by Product
      • 7.3.5.4.2. Market size and forecast, by Application
      • 7.3.5.4.3. Market size and forecast, by End User
      • 7.3.5.5. Spain
      • 7.3.5.5.1. Market size and forecast, by Product
      • 7.3.5.5.2. Market size and forecast, by Application
      • 7.3.5.5.3. Market size and forecast, by End User
      • 7.3.5.6. Rest of Europe
      • 7.3.5.6.1. Market size and forecast, by Product
      • 7.3.5.6.2. Market size and forecast, by Application
      • 7.3.5.6.3. Market size and forecast, by End User
  • 7.4. Asia-Pacific
    • 7.4.1. Key market trends, growth factors and opportunities
    • 7.4.2. Market size and forecast, by Product
    • 7.4.3. Market size and forecast, by Application
    • 7.4.4. Market size and forecast, by End User
    • 7.4.5. Market size and forecast, by country
      • 7.4.5.1. Japan
      • 7.4.5.1.1. Market size and forecast, by Product
      • 7.4.5.1.2. Market size and forecast, by Application
      • 7.4.5.1.3. Market size and forecast, by End User
      • 7.4.5.2. China
      • 7.4.5.2.1. Market size and forecast, by Product
      • 7.4.5.2.2. Market size and forecast, by Application
      • 7.4.5.2.3. Market size and forecast, by End User
      • 7.4.5.3. India
      • 7.4.5.3.1. Market size and forecast, by Product
      • 7.4.5.3.2. Market size and forecast, by Application
      • 7.4.5.3.3. Market size and forecast, by End User
      • 7.4.5.4. Australia
      • 7.4.5.4.1. Market size and forecast, by Product
      • 7.4.5.4.2. Market size and forecast, by Application
      • 7.4.5.4.3. Market size and forecast, by End User
      • 7.4.5.5. South Korea
      • 7.4.5.5.1. Market size and forecast, by Product
      • 7.4.5.5.2. Market size and forecast, by Application
      • 7.4.5.5.3. Market size and forecast, by End User
      • 7.4.5.6. Rest of Asia-Pacific
      • 7.4.5.6.1. Market size and forecast, by Product
      • 7.4.5.6.2. Market size and forecast, by Application
      • 7.4.5.6.3. Market size and forecast, by End User
  • 7.5. LAMEA
    • 7.5.1. Key market trends, growth factors and opportunities
    • 7.5.2. Market size and forecast, by Product
    • 7.5.3. Market size and forecast, by Application
    • 7.5.4. Market size and forecast, by End User
    • 7.5.5. Market size and forecast, by country
      • 7.5.5.1. Brazil
      • 7.5.5.1.1. Market size and forecast, by Product
      • 7.5.5.1.2. Market size and forecast, by Application
      • 7.5.5.1.3. Market size and forecast, by End User
      • 7.5.5.2. Saudi Arabia
      • 7.5.5.2.1. Market size and forecast, by Product
      • 7.5.5.2.2. Market size and forecast, by Application
      • 7.5.5.2.3. Market size and forecast, by End User
      • 7.5.5.3. South Africa
      • 7.5.5.3.1. Market size and forecast, by Product
      • 7.5.5.3.2. Market size and forecast, by Application
      • 7.5.5.3.3. Market size and forecast, by End User
      • 7.5.5.4. Rest of Asia-Pacific
      • 7.5.5.4.1. Market size and forecast, by Product
      • 7.5.5.4.2. Market size and forecast, by Application
      • 7.5.5.4.3. Market size and forecast, by End User

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product mapping of top 10 player
  • 8.4. Competitive dashboard
  • 8.5. Competitive heatmap
  • 8.6. Top player positioning, 2023

CHAPTER 9: COMPANY PROFILES

  • 9.1. Sartorius AG
    • 9.1.1. Company overview
    • 9.1.2. Key executives
    • 9.1.3. Company snapshot
    • 9.1.4. Operating business segments
    • 9.1.5. Product portfolio
    • 9.1.6. Business performance
    • 9.1.7. Key strategic moves and developments
  • 9.2. Danaher Corporation
    • 9.2.1. Company overview
    • 9.2.2. Key executives
    • 9.2.3. Company snapshot
    • 9.2.4. Operating business segments
    • 9.2.5. Product portfolio
    • 9.2.6. Business performance
  • 9.3. Fujifilm Holdings Corporation
    • 9.3.1. Company overview
    • 9.3.2. Key executives
    • 9.3.3. Company snapshot
    • 9.3.4. Operating business segments
    • 9.3.5. Product portfolio
    • 9.3.6. Business performance
    • 9.3.7. Key strategic moves and developments
  • 9.4. Merck KGaA
    • 9.4.1. Company overview
    • 9.4.2. Key executives
    • 9.4.3. Company snapshot
    • 9.4.4. Operating business segments
    • 9.4.5. Product portfolio
    • 9.4.6. Business performance
    • 9.4.7. Key strategic moves and developments
  • 9.5. Lonza
    • 9.5.1. Company overview
    • 9.5.2. Key executives
    • 9.5.3. Company snapshot
    • 9.5.4. Operating business segments
    • 9.5.5. Product portfolio
    • 9.5.6. Business performance
    • 9.5.7. Key strategic moves and developments
  • 9.6. PAN-Biotech
    • 9.6.1. Company overview
    • 9.6.2. Key executives
    • 9.6.3. Company snapshot
    • 9.6.4. Operating business segments
    • 9.6.5. Product portfolio
  • 9.7. Corning Incorporated
    • 9.7.1. Company overview
    • 9.7.2. Key executives
    • 9.7.3. Company snapshot
    • 9.7.4. Operating business segments
    • 9.7.5. Product portfolio
    • 9.7.6. Business performance
  • 9.8. MP Biomedicals
    • 9.8.1. Company overview
    • 9.8.2. Key executives
    • 9.8.3. Company snapshot
    • 9.8.4. Operating business segments
    • 9.8.5. Product portfolio
  • 9.9. Bio-Techne
    • 9.9.1. Company overview
    • 9.9.2. Key executives
    • 9.9.3. Company snapshot
    • 9.9.4. Operating business segments
    • 9.9.5. Product portfolio
    • 9.9.6. Business performance
  • 9.10. Thermo Fisher Scientific Inc.
    • 9.10.1. Company overview
    • 9.10.2. Key executives
    • 9.10.3. Company snapshot
    • 9.10.4. Operating business segments
    • 9.10.5. Product portfolio
    • 9.10.6. Business performance